Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study

BACKGROUND: Eribulin is a nontaxane microtubule inhibitor with activity in patients with metastatic breast cancer (MBC). We conducted a phase I dose-finding study of eribulin and capecitabine in patients with MBC pretreated with anthracycline and taxane. METHODS: Women with MBC aged ≤70 years were e...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Breast Cancer
Autors principals: Hattori, Masaya, Ishiguro, Hiroshi, Masuda, Norikazu, Yoshimura, Akiyo, Ohtani, Shoichiro, Yasojima, Hiroyuki, Morita, Satoshi, Ohno, Shinji, Iwata, Hiroji
Format: Artigo
Idioma:Inglês
Publicat: Springer Japan 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5741785/
https://ncbi.nlm.nih.gov/pubmed/28861862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12282-017-0798-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars